- 专利标题： CREATINE ORAL SUPPLEMENTATION USING CREATINE HYDROCHLORIDE SALT
-
申请号： US16504702申请日： 2019-07-08
-
公开(公告)号： US20190328693A1公开(公告)日： 2019-10-31
- 发明人: Donald W. Miller , Jonathan L. Vennerstrom , Mark C. Faulkner
- 申请人： Vireo Systems, Inc. , Board of Regents of the University of Nebraska
- 申请人地址： US TN Madison US NE Lincoln
- 专利权人： Vireo Systems, Inc.,Board of Regents of the University of Nebraska
- 当前专利权人： Vireo Systems, Inc.,Board of Regents of the University of Nebraska
- 当前专利权人地址： US TN Madison US NE Lincoln
- 主分类号： A61K31/198
- IPC分类号： A61K31/198 ; A61K31/195 ; A23K20/10 ; A61K31/185 ; A23L2/52 ; A23L33/175 ; A61K31/661 ; A61K9/00 ; A23K50/10 ; A23K20/142 ; A23K20/105 ; A23L33/10
摘要：
The present invention is directed to an oral supplement including creatine hydrochloride, which has an aqueous solubility that is at least 15 times greater than creatine monohydrate, where the oral supplement drives significant improvements in muscle development and recovery due to its enhanced bio-availability, while causing fewer negative side effects compared to previous forms of creatine.
公开/授权文献
信息查询
IPC分类:
